Last reviewed · How we verify

NCT02861729

Clinical Outcomes of Zirconia-reinforced Lithium Silicate Partial Coverage Crowns Compared to Lithium Disilicate Partial Coverage Crowns

Completed NA Last updated 6 February 2019
What this trial tests

NA trial testing Vita Suprinity in Partial Coverage Restoration in 46 participants. Completed in 18 July 2018.

Timeline
1 May 2017
Primary endpoint
18 June 2018
18 July 2018

Quick facts

Lead sponsorCairo University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment46
Start date1 May 2017
Primary completion18 June 2018
Estimated completion18 July 2018
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 18 to 50, any sex, with Partial Coverage Restoration. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this randomized controlled clinical trial is to evaluate the clinical outcomes of Partial Coverage Restorations fabricated with zirconia-reinforced lithium silicate ceramic system compared to partial coverage restorations fabricated with lithium disilicate ceramic system.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Clinical outcomes of zirconia-reinforced lithium silicate partial coverage crowns compared to lithium disilicate partial coverage crowns. A randomized controlled split-mouth clinical study
    Nassar H, H Halim C, A Katamish H. · · 2019 · cited 4× · DOI 10.12688/f1000research.18274.1

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02861729.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing